Global Topical Steroids Market Forecast: Industry Size, Growth and Analysis Insights
Report ID : 1371960 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Topical Steroids Market is categorized based on Drug Class (Low-Potency Topical Steroids, Medium-Potency Topical Steroids, High-Potency Topical Steroids, Super High-Potency Topical Steroids) and Formulation Type (Creams, Ointments, Lotions, Gels, Foams) and End User (Hospitals, Dermatology Clinics, Homecare Settings, Pharmacies) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
Estimated at 5.2 billion USD in 2023, the Topical Steroids Market size is forecasted to reach 8.1 billion USD by 2033, exhibiting a CAGR of 4.5% between 2024 and 2033. The report includes various segments and analyzes key trends and factors that play a significant role in the market.
According to the representatives of the National Skin Center A Society, the market of topical steroids is expected to grow at a steady pace in the near future owing to the rising awareness regarding treatment options of skin diseases and the increasing prevalence of such diseases. This growth can also be attributed to the treating of multiple conditions such as eczema, which involves significant inflammation. Alsopatients are now able to avail of specialized treatment that provides for the management of skin diseases by the use of topical corticosteroids. So seeing the potential that this field has attracted, many top players as well as new entrants made massive investments in R&D to expand their product portfolios.
Furthermore, there’s a rise in the incidence of skin issues which is also backed bynew regulations and a change in how the healthcare industry views itself, i.e.: Being more patient-centred. Combination therapies aided by novel delivery systems are rapidly becoming the latest in dermatologic treatment. In addition, the wider distribution of dermatology clinics and the increased use of telemedicine made it more convenient to obtain topical steroids making it easier to obtain these steroids. Since the dynamics of the dermatology market are changing, it is expected that there will be considerable growth in the market for topical steroid in skin care in the coming years.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Johnson & Johnson, Mylan N.V., AbbVie Inc., Sanofi S.A., Novartis AG, Roche Holding AG, Lupin Pharmaceuticals Inc., AstraZeneca plc |
| SEGMENTS COVERED |
By Drug Class - Low-Potency Topical Steroids, Medium-Potency Topical Steroids, High-Potency Topical Steroids, Super High-Potency Topical Steroids
By Formulation Type - Creams, Ointments, Lotions, Gels, Foams
By End User - Hospitals, Dermatology Clinics, Homecare Settings, Pharmacies
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Topical Steroids Market Dynamics
The Topical Steroids Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Topical Steroids Market Segmentations
Market Breakup by Drug Class
- Overview
- Low-Potency Topical Steroids
- Medium-Potency Topical Steroids
- High-Potency Topical Steroids
- Super High-Potency Topical Steroids
Market Breakup by Formulation Type
- Overview
- Creams
- Ointments
- Lotions
- Gels
- Foams
Market Breakup by End User
- Overview
- Hospitals
- Dermatology Clinics
- Homecare Settings
- Pharmacies
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Topical Steroids Market
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Pfizer Inc.
- GlaxoSmithKline plc
- Bayer AG
- Johnson & Johnson
- Mylan N.V.
- AbbVie Inc.
- Sanofi S.A.
- Novartis AG
- Roche Holding AG
- Lupin Pharmaceuticals Inc.
- AstraZeneca plc
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved